Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Short-term efficacy of rituximab versus tacrolimus in steroid-dependent nephrotic syndrome.

Sinha A, Bagga A, Gulati A, Hari P.

Pediatr Nephrol. 2012 Feb;27(2):235-41. doi: 10.1007/s00467-011-1997-4. Epub 2011 Sep 16.

PMID:
21922213
2.

Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.

Bagga A, Hari P, Moudgil A, Jordan SC.

Am J Kidney Dis. 2003 Dec;42(6):1114-20.

PMID:
14655181
3.

Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.

Sinha MD, MacLeod R, Rigby E, Clark AG.

Nephrol Dial Transplant. 2006 Jul;21(7):1848-54. Epub 2005 Nov 25.

4.

Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome.

Ito S, Kamei K, Ogura M, Sato M, Fujimaru T, Ishikawa T, Udagawa T, Iijima K.

Pediatr Nephrol. 2011 Oct;26(10):1823-8. doi: 10.1007/s00467-011-1886-x. Epub 2011 May 10.

PMID:
21556716
5.

Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report.

Gulati A, Sinha A, Jordan SC, Hari P, Dinda AK, Sharma S, Srivastava RN, Moudgil A, Bagga A.

Clin J Am Soc Nephrol. 2010 Dec;5(12):2207-12. doi: 10.2215/CJN.03470410. Epub 2010 Aug 26.

6.

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.

Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y; Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group.

Lancet. 2014 Oct 4;384(9950):1273-81. doi: 10.1016/S0140-6736(14)60541-9. Epub 2014 Jun 22.

PMID:
24965823
7.

[Long-term prognosis of patients with steroid-dependent nephrotic syndrome treated with rituximab].

Kamei K, Okada M, Miyazono A, Sato M, Fujimaru T, Ogura M, Ito S.

Nihon Jinzo Gakkai Shi. 2013;55(5):947-55. Japanese.

PMID:
23980480
8.

Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery.

Sellier-Leclerc AL, Baudouin V, Kwon T, Macher MA, Guérin V, Lapillonne H, Deschênes G, Ulinski T.

Nephrol Dial Transplant. 2012 Mar;27(3):1083-9. doi: 10.1093/ndt/gfr405. Epub 2011 Aug 1.

9.

Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome.

Sinha A, Bhatia D, Gulati A, Rawat M, Dinda AK, Hari P, Bagga A.

Nephrol Dial Transplant. 2015 Jan;30(1):96-106. doi: 10.1093/ndt/gfu267. Epub 2014 Aug 13.

PMID:
25121488
10.

Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome.

Afzal K, Bagga A, Menon S, Hari P, Jordan SC.

Pediatr Nephrol. 2007 Dec;22(12):2059-65. Epub 2007 Oct 16.

PMID:
17938973
11.

Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome.

Ito S, Kamei K, Ogura M, Udagawa T, Fujinaga S, Saito M, Sako M, Iijima K.

Pediatr Nephrol. 2013 Feb;28(2):257-64. doi: 10.1007/s00467-012-2319-1. Epub 2012 Oct 10.

PMID:
23052656
12.

Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.

Chen SY, Wu CY, Tsai IJ, Tsau YK.

Nephrology (Carlton). 2010 Apr;15(3):336-9. doi: 10.1111/j.1440-1797.2009.01190.x.

PMID:
20470303
13.

Levamisole therapy in corticosteroid-dependent nephrotic syndrome.

Bagga A, Sharma A, Srivastava RN.

Pediatr Nephrol. 1997 Aug;11(4):415-7.

PMID:
9260236
14.

Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome.

Aizawa-Yashiro T, Tsuruga K, Watanabe S, Oki E, Ito E, Tanaka H.

Pediatr Nephrol. 2011 Aug;26(8):1255-61. doi: 10.1007/s00467-011-1876-z. Epub 2011 Apr 9.

PMID:
21479767
15.

Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.

Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.

Am J Kidney Dis. 2009 May;53(5):760-9. doi: 10.1053/j.ajkd.2008.11.033. Epub 2009 Mar 5.

PMID:
19268410
16.

Transient insulin-dependent diabetes mellitus in children with steroid-dependent idiopathic nephrotic syndrome during tacrolimus treatment.

Dittrich K, Knerr I, Rascher W, Dötsch J.

Pediatr Nephrol. 2006 Jul;21(7):958-61. Epub 2006 May 9.

PMID:
16773407
17.

Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome.

Wang W, Xia Y, Mao J, Chen Y, Wang D, Shen H, Fu H, Du L, Liu A.

Pediatr Nephrol. 2012 Nov;27(11):2073-9. doi: 10.1007/s00467-012-2228-3. Epub 2012 Jun 20.

PMID:
22714672
18.

Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome.

Kemper MJ, Gellermann J, Habbig S, Krmar RT, Dittrich K, Jungraithmayr T, Pape L, Patzer L, Billing H, Weber L, Pohl M, Rosenthal K, Rosahl A, Mueller-Wiefel DE, Dötsch J.

Nephrol Dial Transplant. 2012 May;27(5):1910-5. doi: 10.1093/ndt/gfr548. Epub 2011 Nov 9.

19.

Long-term effects of levamisole treatment in childhood nephrotic syndrome.

Sümegi V, Haszon I, Iványi B, Bereczki C, Papp F, Túri S.

Pediatr Nephrol. 2004 Dec;19(12):1354-60.

PMID:
15517419
20.

Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.

El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.

Nephrol Dial Transplant. 2005 Nov;20(11):2433-8. Epub 2005 Oct 4.

Items per page

Supplemental Content

Write to the Help Desk